Chemoinformaics analysis of 6,7-Dimethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline
| Molecular Weight | 207.273 | nRot | 2 |
| Heavy Atom Molecular Weight | 190.137 | nRig | 11 |
| Exact Molecular Weight | 207.126 | nRing | 2 |
| Solubility: LogS | -0.786 | nHRing | 1 |
| Solubility: LogP | 1.391 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 34.0795 |
| nHD | 1 | BPOL | 21.0965 |
| QED | 0.803 |
| Synth | 2.652 |
| Natural Product Likeliness | 1.083 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.963 |
| HIA | 0.004 |
| CACO-2 | -4.594 |
| MDCK | 0.0000128 |
| BBB | 0.67 |
| PPB | 0.1797 |
| VDSS | 2.837 |
| FU | 0.651232 |
| CYP1A2-inh | 0.185 |
| CYP1A2-sub | 0.853 |
| CYP2c19-inh | 0.034 |
| CYP2c19-sub | 0.915 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.24 |
| CYP2d6-inh | 0.364 |
| CYP2d6-sub | 0.92 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.79 |
| CL | 6.946 |
| T12 | 0.695 |
| hERG | 0.053 |
| Ames | 0.113 |
| ROA | 0.56 |
| SkinSen | 0.149 |
| Carcinogencity | 0.054 |
| EI | 0.02 |
| Respiratory | 0.926 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.621505 |